Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 4 (2007), Issue 2 (February)

1. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
   N Engl J Med, 356(6): 580-92. [Abstract] [Full-text]
2. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
   Nature, 445(7128): 648-51. [Abstract] [Full-text]
3. Nature of cell kinetics in psoriatic epidermis.
   J Cutan Pathol, 34(3): 257-63. [Abstract] [Full-text]
4. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque.
   J Cutan Pathol, 34(3): 213-9. [Abstract] [Full-text]
5. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.
   Arthritis Rheum, 56(2): 476-88. [Abstract] [Full-text]
6. Pathogenesis and therapy of psoriasis.
   Nature, 445(7130): 866-73. [Abstract] [Full-text]
7. Psoriasis, innate immunity, and gene pools.
   J Am Acad Dermatol, 56(3): 468-71. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.